Rivaroxaban Recruiting Phase 4 Trials for Transient Ischaemic Attack (TIA) / Cerebral Infarctions Treatment

IndicationsStatusPurposePhase
RecruitingTreatment4
clinicaltrials.gov IdentifierTitleDrugs
NCT03749057Early Rivaroxaban for Acute Ischemic Stroke or TIA Patients With Atrial Fibrillation